Home › Therapeutic areas › Infectious Disease › COVID-19
COVID-19 (4 companies)
Companies with an active program in COVID-19.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| CAPR | Capricor Therapeutics | Infectious DiseaseNeurology Rare | 1 | NDA Submitted | $523M | 2 |
| ENTA | Enanta Pharmaceuticals | DermatologyImmunology+1 | 1 | Approved | $320M | 7 |
| IVVD | Invivyd | Infectious Disease | 3 | Approved | $166M | 5 |
| OCGN | Ocugen | Infectious DiseaseOphthalmology Rare | 2 | Phase 3 | $314M | 12 |
No companies match.